Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Conversion to CREXONT® in the RISE-PD Phase 3 Trial Improved Aspects of Sleep as Measured by the Parkinson’s Disease Sleep Scale-2 (PDSS-2)

              Author:Ondo, William   Hauser, Robert   Grieb, Zachary   Banisadr, Ghazal   Fisher, Stanley   

              Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

              Topic:Movement Disorders  

              Program Number:P11.004  

              Author Institution:Methodist Neurological Institute, Houston, TX  Movement Disorders Center, Tampa, FL  Amneal Pharmaceuticals, Bridgewater, NJ  Amneal Pharmaceuticals, Evanston, IL  Amneal Pharmaceuticals, Warren, NJ